18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

Tina Binderup; Ulrich Knigge; Annika Loft Jakobsen; Birgitte Hartnack Federspiel; Andreas Kjær

doi:10.1158/1078-0432.CCR-09-1759

18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

Tina Binderup, Ulrich Knigge, Annika Loft Jakobsen, Birgitte Hartnack Federspiel, Andreas Kjær

437 Citations (Scopus)

Abstract

(18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) is currently not used on a routine basis for imaging of neuroendocrine (NE) tumors. The aim of this study was to investigate the prognostic value of FDG-PET in patients with NE tumors.

Original language	English
Journal	Clinical Cancer Research
Volume	16
Issue number	3
Pages (from-to)	978-85
Number of pages	8
ISSN	1078-0432
DOIs	https://doi.org/10.1158/1078-0432.CCR-09-1759
Publication status	Published - 1 Feb 2010

Access to Document

10.1158/1078-0432.CCR-09-1759

Cite this

@article{bd9c9a564a6f425d94ce9aac4e784879,

title = "18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors",

abstract = "(18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) is currently not used on a routine basis for imaging of neuroendocrine (NE) tumors. The aim of this study was to investigate the prognostic value of FDG-PET in patients with NE tumors.",

author = "Tina Binderup and Ulrich Knigge and Jakobsen, \{Annika Loft\} and Federspiel, \{Birgitte Hartnack\} and Andreas Kj{\ae}r",

year = "2010",

month = feb,

day = "1",

doi = "10.1158/1078-0432.CCR-09-1759",

language = "English",

volume = "16",

pages = "978--85",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "3",

}

TY - JOUR

T1 - 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

AU - Binderup, Tina

AU - Knigge, Ulrich

AU - Jakobsen, Annika Loft

AU - Federspiel, Birgitte Hartnack

AU - Kjær, Andreas

PY - 2010/2/1

Y1 - 2010/2/1

N2 - (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) is currently not used on a routine basis for imaging of neuroendocrine (NE) tumors. The aim of this study was to investigate the prognostic value of FDG-PET in patients with NE tumors.

AB - (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) is currently not used on a routine basis for imaging of neuroendocrine (NE) tumors. The aim of this study was to investigate the prognostic value of FDG-PET in patients with NE tumors.

UR - https://www.scopus.com/pages/publications/76049085252

U2 - 10.1158/1078-0432.CCR-09-1759

DO - 10.1158/1078-0432.CCR-09-1759

M3 - Journal article

C2 - 20103666

SN - 1078-0432

VL - 16

SP - 978

EP - 985

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 3

ER -

18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

Abstract

Access to Document

Other files and links

Fingerprint

Cite this